Recorded Webinar with Dr. Susana G. Gomez: Quality Cord in Cord Blood Banking
Share the Science
Watch the recorded webinar to hear Dr. Susana Gomez, Director of the Cord Blood Bank at Anthony Nolan Cell Therapy Centre in the UK, speak about quality cord in cord blood banking.
Since the first cord blood transplant was performed in 1988, cord blood has been a valuable option for stem cell transplantation, and cord blood banks have become important factors in transplantation. Watch the recording for an in-depth look at the quality criteria (safety, identity, purity, potency) that cord blood banks must follow to meet NetCord FACT standards. The webinar also covers the important role of qualifications/validations as well as the quality assurance processes that cord blood banks must have in place to ensure the best possible match for patients in need of transplants.
You will learn:
- The quality assays needed to have high quality cord blood units;
- About NetCord FACT standards, in terms of quality; and
- The importance of validations/qualifications when setting up a cord blood bank.
Dr. Susana Gomez, discusses the important role that cord blood banks play in stem cell transplantation, the quality assays and standards that must be met, and the importance of the validations and qualification processes.
Since 2008, Dr. Susana G. Gomez has served as head of cord blood bank at Anthony Nolan Cell Therapy Centre (ANCTC), which is a FACT NetCord accredited facility in Nottingham (UK). She is also the designated individual (DI) for the Human Tissue Authority (HTA) license, and she has a Visiting Fellow in College of Science in Nottingham Trent University.
Dr. Gomez, who has a Ph.D. in hematotoxicity, started her career at Pharma Mar S.A., researching the toxicity of antitumoral drugs in hematopoietic progenitor and hematopoietic stem cells. She has been involved in clinical trials and has extensive experience in mesenchymal stem cell research as well as GMP compliance. Today, she is working to develop new procedures and strategies to achieve better quality and productivity in cord blood units used for cell therapy.
Mediware and Save the Cord Foundation are proud to bring you this exclusive speaker series to discuss the topics you and your peers are most interested in. Join us as we feature your colleagues to discuss their latest research, opinions on industry news and so much more. We look forward to having you on board for this exciting new series!